NEW YORK--(BUSINESS WIRE)--Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drugs against gastrointestinal disorders and cancer announced today that it will hold an investor teleconference on January 14, 2008 at 10:00 AM EST to provide additional details regarding its strategic initiative to develop Guanilib for gastrointestinal disorders.
